Immunocore Holdings plc

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6
Rok finansowy 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 24 26 30 27 144 249 310
Przychód Δ r/r 0.0% 8.5% 17.3% -11.9% 442.0% 73.5% 24.4%
Marża brutto 100.0% -289.5% -148.4% -176.1% 99.7% 99.6% 99.1%
EBIT (mln) -93 -118 -86 -135 -40 -60 -70
EBIT Δ r/r 0.0% 26.6% -27.2% 56.8% -70.7% 50.6% 18.1%
EBIT (%) -395.1% -460.9% -286.2% -509.7% -27.6% -23.9% -22.7%
Koszty finansowe (mln) 1 4 3 6 8 5 19
EBITDA (mln) -81 -108 -75 -135 -36 -38 -70
EBITDA(%) -342.2% -419.6% -250.5% -509.5% -25.4% -15.4% -22.7%
Podatek (mln) -17 -22 -13 -9 -3 -6 -2
Zysk Netto (mln) -72 -104 -74 -132 -41 -55 -51
Zysk netto Δ r/r 0.0% 45.1% -28.7% 77.5% -68.7% 34.1% -7.6%
Zysk netto (%) -302.8% -404.9% -246.0% -495.9% -28.7% -22.2% -16.5%
EPS -0.0026 -0.0038 -2.33 -3.1 -0.9 -0.0011 -1.02
EPS (rozwodnione) -0.0026 -0.0038 -2.33 -3.0 -0.9 -0.0011 -1.02
Ilośc akcji (mln) 27,307 27,307 32 42 46 48,889 50
Ważona ilośc akcji (mln) 27,307 27,307 32 44 46 48,889 50
Waluta GBP GBP GBP GBP GBP USD USD